Id |
Subject |
Object |
Predicate |
Lexical cue |
T209 |
0-256 |
Sentence |
denotes |
BLT1 has also been shown to be a receptor for RvE1 although its clone, high-affinity leukotriene B4 (LTB4) is a potent lipid inflammatory chemoattractant, inducing T helper cell chemotaxis and early effector T cell recruitment through BLT1 (Yokomizo et al. |
T210 |
257-275 |
Sentence |
denotes |
1997; Arita et al. |
T211 |
276-282 |
Sentence |
denotes |
2007). |
T212 |
283-501 |
Sentence |
denotes |
BLT1 shares 21% sequence identity with chemerin1; while this value is relatively low, selective BLT1 antagonist U-75,302 has been demonstrated to replace the binding of [3H]-RvE1 to the human PMN membrane (Arita et al. |
T213 |
502-508 |
Sentence |
denotes |
2007). |
T214 |
509-691 |
Sentence |
denotes |
Besides, although RvE1 is 100 times less potent than LTB4, it inhibited adenylate cyclase activity and induced intracellular calcium mobilization in HEK293 cells overexpressing BLT1. |
T215 |
692-891 |
Sentence |
denotes |
These data indicate the role of RvE1 in reducing BLT1-induced inflammation by RvE1 acting as a partial agonist that competes with LTB4-mediated NF-κB activation and calcium mobilization (Arita et al. |
T216 |
892-898 |
Sentence |
denotes |
2007). |